Parseghian v. Frequency Therapeutics, Inc.

CourtCourt of Chancery of Delaware
DecidedJune 21, 2022
DocketC.A. No. 2021-0551-PAF
StatusPublished

This text of Parseghian v. Frequency Therapeutics, Inc. (Parseghian v. Frequency Therapeutics, Inc.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Parseghian v. Frequency Therapeutics, Inc., (Del. Ct. App. 2022).

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

GREGORY J. PARSEGHIAN as trustee ) of THE GREGORY J. PARSEGHIAN ) REVOCABLE TRUST and ) CHRISTINE M. PARSEGHIAN as ) trustee of THE CHRISTINE M. ) PARSEGHIAN REVOCABLE TRUST, ) ) Plaintiffs, ) ) v. ) C.A. No. 2021-0551-PAF ) FREQUENCY THERAPEUTICS, ) INC., DAVID LUCCHINO, ) COMPUTERSHARE INC., and ) COMPUTERSHARE TRUST ) COMPANY, N.A., ) ) Defendants. )

MEMORANDUM OPINION

Date Submitted: March 23, 2022 Date Decided: June 21, 2022

Samuel T. Hirzel, II, Jamie L. Brown, HEYMAN ENERIO GATTUSO & HIRZEL LLP, Wilmington, Delaware; Adam C. Ford, Matthew A. Ford, FORD O’BRIEN, LLP, New York, New York; Attorneys for Plaintiffs Gregory J. Parseghian as Trustee of The Gregory J. Parseghian Revocable Trust and Christine M. Parseghian as Trustee of The Christine M. Parseghian Revocable Trust.

Elena C. Norman, YOUNG CONAWAY STARGATT & TAYLOR LLP, Wilmington, Delaware; Deborah S. Birnbach, Jennifer Burns Luz, Matthew T. White, GOODWIN PROCTOR LLP, Boston, Massachusetts; Attorneys for Defendants Frequency Therapeutics, Inc. and David Lucchino.

Kevin R. Shannon, Jaclyn C. Levy, Callan R. Jackson, POTTER ANDERSON & CORROON LLP, Wilmington, Delaware; Seth Goldman, Jacob H. Hupart, MINTZ, LEVIN, COHN, FERRIS, GLOVSKY and POPEO, P.C., New York, New York; Attorneys for Defendants Computershare Inc. and Computershare Trust Company, N.A.

FIORAVANTI, Vice Chancellor In early 2021, two related stockholders of Frequency Therapeutics, Inc.

(“Frequency” or the “Company”) decided to sell their shares in the Company amid

a rising stock price. The stockholders and their broker encountered difficulty in

persuading the Company’s stock transfer agent to transfer their shares to their

brokerage account due to what the transfer agent represented as inconsistencies

between the description of the accounts on the transfer agent’s records and those of

the broker. The shares were finally transferred six weeks after the stockholders

initiated their efforts to transfer and sell the stock. Unfortunately for the

stockholders, the Company issued negative news on the day before the shares were

transferred, causing a one-day drop in market price from $36.29 to $7.99 per share.

The plaintiffs have asserted a laundry list of claims and legal theories,

including that the Company’s Chief Executive Officer (“CEO”) breached his

fiduciary duty to the plaintiffs by causing the stock transfer agent to block plaintiffs’

transfer requests so that the CEO could profit from making his own sales in the

market. As the theory goes, the CEO probably knew about the negative corporate

news while he was selling stock during the time that the plaintiffs were unable to

transfer and sell their own shares.

The fiduciary duty claim has all the flavor of an insider trading claim under

Brophy v. Cities Service Co., 70 A.2d 5 (Del. Ch. 1949). But the plaintiffs insist that

is not their claim. Instead, the plaintiffs maintain that they are asserting a direct fiduciary duty claim against the CEO for blocking their stock transfer while profiting

on his own stock sales ahead of announcing bad news. The breach of fiduciary duty

claim fails because it is entirely conclusory with no supporting facts. There are no

allegations that this CEO of a publicly traded company had any communications

with the transfer agent about the plaintiffs’ shares. Indeed, there are no allegations

that the CEO knew that the plaintiffs had sought to sell their shares, let alone any act

on the CEO’s part that could lead to a reasonable inference that he stymied the

plaintiffs’ stock transfer.

The plaintiffs’ remaining claims assert various theories to find the Company

or the transfer agent liable for the damages that the plaintiffs allegedly suffered due

to the delay in effecting the transfer of their shares. The problem for the plaintiffs is

that the court lacks subject matter jurisdiction over the remaining claims. Both

plaintiffs and defendants want these claims litigated in this court. But this court is a

court of limited jurisdiction. The court is duty bound to raise the issue of subject

matter jurisdiction on its own. The court has done so here, and the parties have not

demonstrated that the remaining claims are anything other than legal theories

designed to obtain a judgment for money damages. Although the court could, in the

exercise of discretion, retain jurisdiction under the clean-up doctrine, the court

declines to do so. This case is in its embryonic stages. Now that the only claim for

which the court had jurisdiction is dismissed at the pleadings stage, it is appropriate

2 to decline jurisdiction under the clean-up doctrine and to allow plaintiffs to refile

their remaining claims in the Superior Court. Accordingly, Count II is dismissed for

failure to state a claim upon which relief can be granted. Counts I and III–VI are

dismissed for lack of subject matter jurisdiction.

I. BACKGROUND

The facts recited in this Memorandum Opinion are drawn from the operative

complaint and documents integral thereto or otherwise subject to judicial notice.

A. Factual History

1. The Parties

The plaintiffs in this action are two trusts, The Gregory J. Parseghian

Revocable Trust and The Christine M. Parseghian Revocable Trust (collectively the

“Trusts” and “Plaintiffs”).1 Gregory J. Parseghian and Christine M. Parseghian are

the respective Grantors and Trustees of these trusts.2 The Trusts are purported

stockholders of Frequency.3 The Company is a Delaware corporation with a

principle place of business in Massachusetts.4 Defendant David Lucchino

(“Lucchino”) is a co-founder, CEO, and director of Frequency.5 Defendant

1 Compl. ¶¶ 15–16. 2 Id. 3 Id. ¶ 1. 4 Id. ¶ 18. 5 Id. ¶ 22.

3 Computershare, Inc. and its wholly owned subsidiary, Defendant Computershare

Trust Company N.A., work together as the Company’s transfer agent (collectively

“Computershare”).6 Frequency, Lucchino, and Computershare are herein referred

to as the “Defendants.”

2. The Trusts’ Investment in Frequency

In March 2017, the Trusts purchased 333,333 shares of Frequency Preferred

Stock Series A.7 On October 9, 2017, the Trusts purchased another 149,530

Frequency shares.8 For each of these investments, the purchased shares were divided

equally between the Trusts.9 On October 3, 2019, Frequency commenced its initial

public offering (“IPO”) on the Nasdaq Global Select Market.10 In conjunction with

the IPO, Frequency’s Series A preferred stock was converted into common stock at

a ratio of approximately 6.7 to 1.11 As a result, the Trusts’ 482,863 shares of Series

A preferred were converted to 71,688 shares of common stock.12

6 Id. ¶¶ 19–20. 7 Id. ¶ 24. 8 Id. ¶ 26 9 Id. ¶¶ 25, 27 10 Id. ¶ 30. 11 Id. 12 Id.

4 3. Frequency

Frequency is a biotechnology company focused on developing treatments that

activate targeted regenerative cells in the human body.13 At all times relevant to this

matter, Frequency has been developing one such treatment, “FX-322,” to combat

sensorineural hearing loss (“SNHL”), a condition that includes presbycusis (the

medical name for age-related hearing loss).14

Prior to its public offering, Frequency hired Computershare to provide

Free access — add to your briefcase to read the full text and ask questions with AI

Related

White v. Panic
783 A.2d 543 (Supreme Court of Delaware, 2001)
Candlewood Timber Group, LLC v. Pan American Energy, LLC
859 A.2d 989 (Supreme Court of Delaware, 2004)
In Re Citigroup Inc. Shareholder Derivative Litigation
964 A.2d 106 (Court of Chancery of Delaware, 2009)
Getty Refining & Marketing Co. v. Park Oil, Inc.
385 A.2d 147 (Court of Chancery of Delaware, 1978)
Park Oil, Inc. v. Getty Refining & Marketing Co.
407 A.2d 533 (Supreme Court of Delaware, 1979)
In Re General Motors (Hughes) Shareholder Litigation
897 A.2d 162 (Supreme Court of Delaware, 2006)
El Paso Natural Gas Co. v. TransAmerican Natural Gas Corp.
669 A.2d 36 (Supreme Court of Delaware, 1995)
International Business MacHines Corp. v. Comdisco, Inc.
602 A.2d 74 (Court of Chancery of Delaware, 1991)
Brehm v. Eisner
746 A.2d 244 (Supreme Court of Delaware, 2000)
Savor, Inc. v. FMR Corp.
812 A.2d 894 (Supreme Court of Delaware, 2002)
Nemec v. Shrader
991 A.2d 1120 (Supreme Court of Delaware, 2010)
McMahon v. New Castle Associates
532 A.2d 601 (Court of Chancery of Delaware, 1987)
Gabelli & Co. v. Liggett Group, Inc.
479 A.2d 276 (Supreme Court of Delaware, 1984)
Brophy v. Cities Service Co.
70 A.2d 5 (Court of Chancery of Delaware, 1949)
Harold Kraft v. Wisdomtree Investments, Inc.
145 A.3d 969 (Court of Chancery of Delaware, 2016)
In re Orchard Enterprises, Inc.
88 A.3d 1 (Court of Chancery of Delaware, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Parseghian v. Frequency Therapeutics, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/parseghian-v-frequency-therapeutics-inc-delch-2022.